Celanese Reports Q2 2026 Adjusted EPS of $2.45, Highest in Nearly Three Years; Guides Q3 EPS $1.35-$1.75, Full-Year ~$6.00
CE sits 26% above its 52-week low of $35.13 on elevated volume (2.0× avg).
Summary
Celanese reported Q2 2026 adjusted EPS of $2.45, beating estimates, and guided Q3 EPS of $1.35-$1.75 and full-year ~$6.00. Strong segment performance and free cash flow generation support the company's deleveraging strategy.
Key Events · Earnings and Guidance · CE
-
Q2 2026 Earnings Beat
Adjusted EPS of $2.45 exceeded consensus by $0.22, the highest in nearly three years, driven by strong commercial execution in both Engineered Materials and the Acetyl Chain.
-
Segment Performance Highlights
Engineered Materials posted record variable margin with adjusted EBIT of $234 million; Acetyl Chain delivered $321 million in adjusted EBIT, leveraging Western Hemisphere supply advantages.
-
Q3 and Full-Year Guidance
Q3 2026 adjusted EPS guidance of $1.35-$1.75 reflects normalization of supply-related tailwinds and higher raw material costs; full-year 2026 adjusted EPS guidance maintained at approximately $6.00.
-
Free Cash Flow and Deleveraging
Generated $140 million in free cash flow in Q2; full-year free cash flow target of $700-$800 million reaffirmed, supporting significant expected improvement in net debt-to-operating EBITDA ratio by year-end 2026.
Analysis · CE · Industrial Applications And Services
Celanese delivered its strongest quarterly earnings in nearly three years, with adjusted EPS of $2.45 beating consensus by $0.22. Both business segments posted robust results: Engineered Materials achieved its highest-ever variable margin, driven by growth in medical and electronics, while the Acetyl Chain capitalized on supply disruptions to capture value in the Western Hemisphere. The company generated $140 million in free cash flow and reaffirmed its full-year free cash flow target of $700-$800 million, supporting its deleveraging plan. Q3 guidance of $1.35-$1.75 reflects expected normalization of supply-related opportunities and higher raw material costs, but full-year EPS guidance of ~$6.00 signals confidence in sustained earnings power. The results and outlook reinforce the company's ability to generate cash and reduce debt, a critical focus given its high leverage and recent covenant amendment.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CE was trading at $44.30 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5B. The 52-week trading range was $35.13 to $70.70. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.